• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清促红细胞生成素在真性红细胞增多症诊断及放血治疗后的应用

Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.

作者信息

Birgegård G, Wide L

机构信息

Department of Internal Medicine, University Hospital, Uppsala, Sweden.

出版信息

Br J Haematol. 1992 Aug;81(4):603-6. doi: 10.1111/j.1365-2141.1992.tb02999.x.

DOI:10.1111/j.1365-2141.1992.tb02999.x
PMID:1390249
Abstract

Serum erythropoietin (S-Epo) was measured with a radiommunoassay method in 36 patients with polycythaemia vera, 17 patients with secondary polycythaemia and 14 patients with relative polycythaemia. The diagnoses were made without the aid of the S-Epo values. It was found that S-Epo was below the reference range in 34/36 patients with polycythaemia vera (mean 2.1 +/- 1.0 U/l), elevated in all cases of secondary polycythaemia (mean 121.7 +/- 242 U/l) and normal in all but one of the cases with relative polycythaemia (mean 7.0 +/- 2.5 U/l). Previous studies of S-Epo levels in the differential diagnosis of polycythaemia have shown significant differences between the means of the groups but a considerable overlap. After phlebotomy treatment to normal haematocrit levels, the S-Epo levels remained subnormal in most of the polycythaemia vera patients even after 18 months at a haematocrit around 45%. Two patients who had been kept at normal haematocrit for 6 and 7 years both had subnormal S-Epo. We conclude that with an Epo assay method of high sensitivity and specificity it is possible to differentiate between different forms of polycythaemia with a high degree of certainty, even between patients with relative polycythaemia and polycythaemia vera patients. The reason why S-Epo remains low in spite of a normal haematocrit in treated polycythaemia vera patients is not known.

摘要

采用放射免疫分析法对36例真性红细胞增多症患者、17例继发性红细胞增多症患者和14例相对性红细胞增多症患者进行血清促红细胞生成素(S-Epo)检测。诊断时未借助S-Epo值。结果发现,36例真性红细胞增多症患者中有34例的S-Epo低于参考范围(平均2.1±1.0 U/l),所有继发性红细胞增多症患者的S-Epo均升高(平均121.7±242 U/l),除1例相对性红细胞增多症患者外,其余患者的S-Epo均正常(平均7.0±2.5 U/l)。既往关于S-Epo水平在红细胞增多症鉴别诊断中的研究表明,各组均值之间存在显著差异,但有相当程度的重叠。在放血治疗使血细胞比容水平恢复正常后,大多数真性红细胞增多症患者的S-Epo水平即使在血细胞比容维持在45%左右18个月后仍低于正常水平。2例血细胞比容维持正常6年和7年的患者,其S-Epo均低于正常水平。我们得出结论,使用具有高灵敏度和特异性的促红细胞生成素检测方法,即使在相对性红细胞增多症患者和真性红细胞增多症患者之间,也能够高度准确地区分不同类型的红细胞增多症。尽管治疗后的真性红细胞增多症患者血细胞比容正常,但S-Epo仍保持低水平的原因尚不清楚。

相似文献

1
Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.血清促红细胞生成素在真性红细胞增多症诊断及放血治疗后的应用
Br J Haematol. 1992 Aug;81(4):603-6. doi: 10.1111/j.1365-2141.1992.tb02999.x.
2
In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.红系祖细胞的体外培养生长及血清促红细胞生成素测定在真性红细胞增多症鉴别诊断中的应用
Eur J Clin Invest. 1998 Jul;28(7):569-76. doi: 10.1046/j.1365-2362.1998.00331.x.
3
Erythropoietin measurements in the differential diagnosis of polycythaemia.
Br J Haematol. 1981 Jul;48(3):393-401. doi: 10.1111/j.1365-2141.1981.tb02731.x.
4
Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.真性红细胞增多症和相对性红细胞增多症中的红细胞总量、脾脏大小及血浆促红细胞生成素
Acta Haematol. 2002;108(1):1-7. doi: 10.1159/000063064.
5
The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.血清促红细胞生成素水平及JAK2 V617F等位基因负荷在真性红细胞增多症诊断中的作用。
Br J Haematol. 2014 Nov;167(3):411-7. doi: 10.1111/bjh.13047. Epub 2014 Jul 18.
6
Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias.免疫反应性促红细胞生成素的放射免疫测定作为红细胞增多症分类的临床工具。
Nouv Rev Fr Hematol (1978). 1990;32(4):237-40.
7
Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome.真性红细胞增多症合并布加综合征患者血清促红细胞生成素升高。
BMJ Case Rep. 2014 Dec 1;2014:bcr2014205663. doi: 10.1136/bcr-2014-205663.
8
An evaluation of serum erythropoietin estimation by a hemagglutination inhibition assay in the differential diagnosis of polycythemia.
Pathology. 1984 Apr;16(2):155-6. doi: 10.3109/00313028409059095.
9
Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.采用高灵敏度免疫放射分析法定量检测未经治疗及经治疗的真性红细胞增多症和原发性血小板增多症患者的血浆促红细胞生成素。
Eur J Haematol. 1998 May;60(5):278-82. doi: 10.1111/j.1600-0609.1998.tb01040.x.
10
Erythropoietin radioimmunoassay in evaluating patients with polycythemia.红细胞生成素放射免疫测定在评估真性红细胞增多症患者中的应用
Ann Intern Med. 1981 Jan;94(1):44-7. doi: 10.7326/0003-4819-94-1-44.

引用本文的文献

1
Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia.聚乙二醇干扰素α-2b具有抗真性红细胞增多症活性,且不会引起具有临床意义的贫血。
BJC Rep. 2024 Jul 11;2(1):51. doi: 10.1038/s44276-024-00076-4.
2
Polycythemia Vera With High Serum Erythropoietin Level: A Case Report and Literature Review.血清促红细胞生成素水平升高的真性红细胞增多症:一例报告及文献复习
Cureus. 2024 Sep 17;16(9):e69578. doi: 10.7759/cureus.69578. eCollection 2024 Sep.
3
The Systemic Inflammation Index: A New Candidate Minor Criterion in the Diagnosis of Polycythemia Vera.
全身炎症指数:真性红细胞增多症诊断中一个新的候选次要标准
J Pers Med. 2024 Apr 29;14(5):471. doi: 10.3390/jpm14050471.
4
Cytokine-mediated communication: a quantitative appraisal of immune complexity.细胞因子介导的通讯:对免疫复杂性的定量评估。
Nat Rev Immunol. 2019 Apr;19(4):205-217. doi: 10.1038/s41577-019-0131-x.
5
A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin.促红细胞生成素受体(EPOR)中的截短突变导致对促红细胞生成素反应低下,同时血红蛋白水平正常。
Commun Biol. 2018 May 17;1:49. doi: 10.1038/s42003-018-0053-3. eCollection 2018.
6
Vertebral artery thrombosis: a rare presentation of primary polycythaemia.椎动脉血栓形成:原发性红细胞增多症的一种罕见表现。
BMJ Case Rep. 2014 May 26;2014:bcr2013201347. doi: 10.1136/bcr-2013-201347.
7
JAK2 V617F and the evolving paradigm of polycythemia vera.JAK2 V617F与真性红细胞增多症不断演变的范式
Korean J Hematol. 2010 Jun;45(2):90-4. doi: 10.5045/kjh.2010.45.2.90. Epub 2010 Jun 30.
8
The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis.2008 年世界卫生组织原发性骨髓纤维化、真性红细胞增多症和特发性血小板增多症的诊断标准。
Curr Hematol Malig Rep. 2009 Jan;4(1):33-40. doi: 10.1007/s11899-009-0005-6.
9
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.条件性表达杂合或纯合 Jak2V617F 从其内源启动子诱导类似于真性红细胞增多症的疾病。
Blood. 2010 Apr 29;115(17):3589-97. doi: 10.1182/blood-2009-04-215848. Epub 2010 Mar 2.
10
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化(特发性髓样化生)诊断的临床及病理标准。
Int J Hematol. 2002 Aug;76(2):133-45. doi: 10.1007/BF02982575.